Pages

Friday, January 20, 2017

Politicizing the FDA: What the Trump Win Means for New Pharma ...

Regulatory Focus-11 hours ago
... pointed to recent guidance documents on biosimilars and drug compounding as examples of overdue documents that clarify how laws are to be implemented.
Post a Comment